Vaxart, Inc. Gains 37.46%
Tue, Apr 27, 2021 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) rocketted at $8.33, representing a gain of 37.5%. On Mon, Apr 26, 2021, VXRT:NASDAQ hit a New 2-Week High of $6.06. The stock got featured on our News Catalysts scanner on Mon, Apr 26, 2021 at 09:25 AM in the 'BIOTECH' category. From Mon, Apr 12, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Feb 02, 2021 at $24.9 with a volume of 72M+, and its share price has been moving sideways in recent weeks.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- TerraForm Global, Inc. (GLBL:NASDAQ), 100%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 51.18%
- Urban Tea, Inc. (MYT:NASDAQ), 38.1%
- Vaxart, Inc. (VXRT:NASDAQ), 37.46%
- TIRX (TIRX:NASDAQ), 36.27%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 33.66%
- RiceBran Technologies (RIBT:NASDAQ), 26.88%
- NetSol Technologies, Inc. (NTWK:NASDAQ), 25.29%
- TrueBlue, Inc. (TBI:NYSE), 24.89%
- EEIQ (EEIQ:NASDAQ), 21.23%